| Preview | Issue Date | Title / Name | Author(s) |
| Jul-2022 | Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study | Valerio, H.; Alavi, M.; Conway, A.; Silk, D.; Treloar, C.; Martinello, M.; Milat, A.; Dunlop, A.; Murray, C.; Henderson, C.; Amin, J.; Read, P.; Marks, P.; Degenhardt, L.; Stevens, A.; Prain, B.; Hayllar, J.; Reid, D.; Montebello, M.; Wade, A.; Christmass, M.; Cock, V.; Dore, G. J.; Grebely, J.; Wade, Alexandra | |
| Jun-2025 | Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study | Ang, J.; Hajarizadeh, B.; Tillakeratne, S.; Dore, G. J.; Treloar, C.; Amin, J.; van Dyk, J.; Degenhardt, L.; Applegate, T.; Dunlop, A.; Fraser, C.; Conway, B.; Wong, A.; Fuchs, D.; Powis, J.; Mason, K.; Gane, E. J.; Weltman, M.; Read, P.; Martinello, M.; Rowe, E.; Baker, D. A.; Wade, A.; Matthews, G.; Lafferty, L.; Lloyd, A.; Grebely, J.; Cunningham, E. B.; Wade, Alexandra | |
| Jul-2022 | A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study | Conway, A.; Valerio, H.; Alavi, M.; Silk, D.; Treloar, C.; Hajarizadeh, B.; Marshall, A. D.; Martinello, M.; Milat, A.; Dunlop, A.; Murray, C.; Prain, B.; Henderson, C.; Amin, J.; Read, P.; Marks, P.; Degenhardt, L.; Hayllar, J.; Reid, D.; Gorton, C.; Lam, T.; Christmass, M.; Wade, A.; Montebello, M.; Dore, G. J.; Grebely, J.; ETHOS Engage Study Group; Wade, Alexandra | |
